GlaxoSmithKline
GSK
#279
Rank
C$103.90 B
Marketcap
$50.93
Share price
0.86%
Change (1 day)
-2.78%
Change (1 year)

GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

Volume in USD (price x number of shares), data since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025C$0.03 M-99.97%
2024C$0.14 B395%
2023C$29.9 M-43.98%
2022C$53.37 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
C$60.64 MC$0.20 B๐Ÿ‡ฌ๐Ÿ‡ง UK
C$28.68 MC$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
C$76.76 MC$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
C$81.23 MC$0.14 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$4.02 MC$72.89 M๐Ÿ‡ซ๐Ÿ‡ท France
C$12.17 MC$37.17 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
C$0.68 MC$32.36 M๐Ÿ‡บ๐Ÿ‡ธ USA